201 related articles for article (PubMed ID: 25036364)
21. Neutrophils Turn Plasma Proteins into Weapons against HIV-1.
Speth C; Brodde MF; Hagleitner M; Rambach G; Van Aken H; Dierich M; Kehrel BE
PLoS One; 2013; 8(6):e66073. PubMed ID: 23840401
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of HIV-1 envelope-dependent membrane fusion by serum antilymphocyte autoantibodies is associated with low plasma viral load.
Ruiz-Rivera MB; Gómez-Icazbalceta G; Vélez-Alavez M; Viveros-Rogel M; Pérez-Patrigeon S; Lamoyi E; Llorente L; Núñez-Álvarez CA; Huerta L
Immunol Lett; 2019 Jul; 211():33-40. PubMed ID: 31059733
[TBL] [Abstract][Full Text] [Related]
23. In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4.
Andrianov AM; Nikolaev GI; Kornoushenko YV; Xu W; Jiang S; Tuzikov AV
Viruses; 2019 Aug; 11(8):. PubMed ID: 31412617
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.
Cimbro R; Peterson FC; Liu Q; Guzzo C; Zhang P; Miao H; Van Ryk D; Ambroggio X; Hurt DE; De Gioia L; Volkman BF; Dolan MA; Lusso P
EBioMedicine; 2016 Aug; 10():45-54. PubMed ID: 27389109
[TBL] [Abstract][Full Text] [Related]
25. Surfactant protein A binds to HIV and inhibits direct infection of CD4+ cells, but enhances dendritic cell-mediated viral transfer.
Gaiha GD; Dong T; Palaniyar N; Mitchell DA; Reid KB; Clark HW
J Immunol; 2008 Jul; 181(1):601-9. PubMed ID: 18566427
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry.
Lam SN; Acharya P; Wyatt R; Kwong PD; Bewley CA
Bioorg Med Chem; 2008 Dec; 16(23):10113-20. PubMed ID: 18952441
[TBL] [Abstract][Full Text] [Related]
27. Lineage-specific differences between human and simian immunodeficiency virus regulation of gp120 trimer association and CD4 binding.
Finzi A; Pacheco B; Xiang SH; Pancera M; Herschhorn A; Wang L; Zeng X; Desormeaux A; Kwong PD; Sodroski J
J Virol; 2012 Sep; 86(17):8974-86. PubMed ID: 22696649
[TBL] [Abstract][Full Text] [Related]
28. 2-Aminothiazolones as anti-HIV agents that act as gp120-CD4 inhibitors.
Tiberi M; Tintori C; Ceresola ER; Fazi R; Zamperini C; Calandro P; Franchi L; Selvaraj M; Botta L; Sampaolo M; Saita D; Ferrarese R; Clementi M; Canducci F; Botta M
Antimicrob Agents Chemother; 2014 Jun; 58(6):3043-52. PubMed ID: 24614386
[TBL] [Abstract][Full Text] [Related]
29. MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.
Grupping K; Selhorst P; Michiels J; Vereecken K; Heyndrickx L; Kessler P; Vanham G; Martin L; Ariën KK
Retrovirology; 2012 May; 9():36. PubMed ID: 22551420
[TBL] [Abstract][Full Text] [Related]
30. The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications.
Férir G; Petrova MI; Andrei G; Huskens D; Hoorelbeke B; Snoeck R; Vanderleyden J; Balzarini J; Bartoschek S; Brönstrup M; Süssmuth RD; Schols D
PLoS One; 2013; 8(5):e64010. PubMed ID: 23724015
[TBL] [Abstract][Full Text] [Related]
31. A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry.
Herschhorn A; Gu C; Espy N; Richard J; Finzi A; Sodroski JG
Nat Chem Biol; 2014 Oct; 10(10):845-52. PubMed ID: 25174000
[TBL] [Abstract][Full Text] [Related]
32. A novel class of HIV-1 inhibitors that targets the viral envelope and inhibits CD4 receptor binding.
Wang HG; Williams RE; Lin PF
Curr Pharm Des; 2004; 10(15):1785-93. PubMed ID: 15180540
[TBL] [Abstract][Full Text] [Related]
33. Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions.
Finzi A; Xiang SH; Pacheco B; Wang L; Haight J; Kassa A; Danek B; Pancera M; Kwong PD; Sodroski J
Mol Cell; 2010 Mar; 37(5):656-67. PubMed ID: 20227370
[TBL] [Abstract][Full Text] [Related]
34. Long-Acting BMS-378806 Analogues Stabilize the State-1 Conformation of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins.
Zou S; Zhang S; Gaffney A; Ding H; Lu M; Grover JR; Farrell M; Nguyen HT; Zhao C; Anang S; Zhao M; Mohammadi M; Blanchard SC; Abrams C; Madani N; Mothes W; Kappes JC; Smith AB; Sodroski J
J Virol; 2020 May; 94(10):. PubMed ID: 32161177
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition.
Majerle A; Pristovsek P; Mancek-Keber M; Jerala R
J Biol Chem; 2011 Jul; 286(29):26228-37. PubMed ID: 21636577
[TBL] [Abstract][Full Text] [Related]
36. Surfactant Protein D Reverses the Gene Signature of Transepithelial HIV-1 Passage and Restricts the Viral Transfer Across the Vaginal Barrier.
Pandit H; Kale K; Yamamoto H; Thakur G; Rokade S; Chakraborty P; Vasudevan M; Kishore U; Madan T; Fichorova RN
Front Immunol; 2019; 10():264. PubMed ID: 30984160
[TBL] [Abstract][Full Text] [Related]
37. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.
Fouts TR; Tuskan R; Godfrey K; Reitz M; Hone D; Lewis GK; DeVico AL
J Virol; 2000 Dec; 74(24):11427-36. PubMed ID: 11090138
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the multiple conformational States of free monomeric and trimeric human immunodeficiency virus envelope glycoproteins after fixation by cross-linker.
Yuan W; Bazick J; Sodroski J
J Virol; 2006 Jul; 80(14):6725-37. PubMed ID: 16809278
[TBL] [Abstract][Full Text] [Related]
39. The highly conserved layer-3 component of the HIV-1 gp120 inner domain is critical for CD4-required conformational transitions.
Désormeaux A; Coutu M; Medjahed H; Pacheco B; Herschhorn A; Gu C; Xiang SH; Mao Y; Sodroski J; Finzi A
J Virol; 2013 Mar; 87(5):2549-62. PubMed ID: 23255784
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 gp120-induced tubular epithelial cell apoptosis is mediated through p38-MAPK phosphorylation.
Kapasi AA; Patel G; Franki N; Singhal PC
Mol Med; 2002 Nov; 8(11):676-85. PubMed ID: 12520084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
